Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis (TB TRIAGE+)
Prospective, Multicentre Evaluation of the Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for the Diagnosis of Pulmonary Tuberculosis in Presumptive Adult TB Patients (TB TRIAGE+ Accuracy)
Sponsor: Charite University, Berlin, Germany
This observational or N/A phase trial investigates Covid-19 and HIV and is currently completed. Charite University, Berlin, Germany leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Oct 2025 — Present [monthly]
Completed
-
Sep 2024 — Oct 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2022 — Sep 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Mar 2022 — Jun 2022 [monthly]
Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Recruiting
-
Sep 2021 — Feb 2022 [monthly]
Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Charite University, Berlin, Germany
- European and Developing Countries Clinical Trials Partnership (EDCTP)
- Foundation for Innovative New Diagnostics, Switzerland
- Human Sciences Research Council
- Institute of Tropical Medicine, Belgium
- Klaus Reither
- Ministry of Health, Lesotho
- Radboud University Medical Center
- SolidarMed
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .